In the BioHarmony Drug Report Database
Methyl salicylate
Salonpas (methyl salicylate) is a small molecule pharmaceutical. Methyl salicylate was first approved as Salonpas on 2008-02-20. It is used to treat acute pain, arthritis, back pain, contusions, and inflammation amongst others in the USA. It is known to target transient receptor potential cation channel subfamily A member 1. Tri-luma’s patent is valid until 2030-01-03 (FDA).
Trade Name
|
Salonpas |
|---|---|
Common Name
|
methyl salicylate |
ChEMBL ID
|
CHEMBL108545 |
Indication
|
acute pain, arthritis, back pain, contusions, inflammation, muscle cramp, sprains and strains |
Drug Class
|
Anti-inflammatory agents (salicylic acid derivatives) |
Image (chem structure or protein)